Hany Onsy Habashy

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

Desmond G. Powe, Kurt S. Zänker, Hany Onsy Habashy et al. · Oncotarget · 2010 · 442 citations · Full text

Medicine, Oncology, Pharmacology +17

Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes

Emad A. Rakha, Maysa E. El‐Sayed, Desmond G. Powe et al. · European Journal of Cancer · 2007 · 256 citations

Medicine, Oncology, Surgery +14

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Hany Onsy Habashy, Desmond G. Powe, Cindy M. Staka et al. · Breast Cancer Research and Treatment · 2009 · 239 citations · Full text

Medicine, Cancer Biology, Oncology +13

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance

Hany Onsy Habashy, Desmond G. Powe, Emad A. Rakha et al. · European Journal of Cancer · 2008 · 100 citations

Medicine, Cancer Biology, Oncology +15

Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study

D. G. Powe, Hany Onsy Habashy, Kurt S. Zänker et al. · Breast Cancer Research and Treatment · 2011 · 94 citations

Medicine, Molecular Biology, Oncology +13